Guillaume Chaby
Dermatology — Centre Hospitalier Universitaire Amiens-Picardie, France
Guillaume Chaby
LeadR Profile
Dermatology
Subspecialties: Public Health - Immunology - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2005 - 2026
Number : 278
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Leg-type diffuse large-cell lymphoma of the nasal area treated with contact radiotherapy. radiotherapy, cells, lymphoma, lymphoma, large b-cell, diffuse | Dermatol Online J | 2026 | 0 |
| Management of erythromelalgia: A retrospective multicenter study. sexually transmitted diseases, erythromelalgia, dermatology | Ann Dermatol Venereol | 2026 | 0 |
| Vulvar findings and sexual dysfunction in women with systemic sclerosis. sclerosis, carcinoma, squamous cell, lichen sclerosus et atrophicus, vulvodynia, scleroderma, systemic | JAAD Int | 2026 | 0 |
| A neutrotrophic trigeminal ulceration. trigeminal nerve | JAAD Case Rep | 2025 | 0 |
| Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies. skin, ivermectin, absenteeism, permethrin, scabies, therapeutics | N Engl J Med Top journal | 2026 | 0 |
Clinical Studies 16
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate to Severe Atopic Dermatitis 2023-508235-31-00 — safety, dermatitis, signs and symptoms, adolescent, therapeutics, dermatitis, atopic | Phase 3 | Active not recruiting | 2024 |
| Phase 2 Proof of Concept Study of LAD328 in Adults with Hidradenitis Suppurativa 2025-521865-29-00 — safety, hidradenitis suppurativa, proof of concept study, hidradenitis | Phase 2 | Recruiting | 2026 |
| Prophylaxis of Recurrent Erysipelas in Lower Limbs compreSsion thErapy vs aNTibiotics and Compression Therapy NCT07549594 — nurses, research design, cellulitis, telemedicine, emollients, erysipelas, penicillin v, therapeutics, random allocation, infections, stockings, compression, male | Phase 4 | Not yet recruiting | 2026 |
| Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus NCT05898308 — injections, skin, antibodies, adrenal cortex hormones, skin diseases, desmogleins, biomarkers, maintenance, rituximab, precision medicine, acantholysis, therapeutics, pemphigus | Phase 4 | Recruiting | 2024 |
| Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis NCT04227314 — stomatitis, aphthous, safety, tablets, stomatitis, therapeutics | Phase 3 | Recruiting | 2022 |
LeadR Networks
Main global connection map